0001209191-21-059948.txt : 20211007
0001209191-21-059948.hdr.sgml : 20211007
20211007170318
ACCESSION NUMBER: 0001209191-21-059948
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211005
FILED AS OF DATE: 20211007
DATE AS OF CHANGE: 20211007
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HILZINGER KURT J
CENTRAL INDEX KEY: 0001191504
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37759
FILM NUMBER: 211312963
MAIL ADDRESS:
STREET 1: 1300 MORRIS DRIVE
STREET 2: SUITE 100
CITY: CHESTERBROOK
STATE: PA
ZIP: 19087
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outlook Therapeutics, Inc.
CENTRAL INDEX KEY: 0001649989
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 383982704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 485 ROUTE 1 SOUTH
STREET 2: BUILDING F, SUITE 320
CITY: ISELIN
STATE: NJ
ZIP: 08830
BUSINESS PHONE: 6096193990
MAIL ADDRESS:
STREET 1: 485 ROUTE 1 SOUTH
STREET 2: BUILDING F, SUITE 320
CITY: ISELIN
STATE: NJ
ZIP: 08830
FORMER COMPANY:
FORMER CONFORMED NAME: Oncobiologics, Inc.
DATE OF NAME CHANGE: 20150804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-10-05
0
0001649989
Outlook Therapeutics, Inc.
OTLK
0001191504
HILZINGER KURT J
C/O OUTLOOK THERAPEUTICS, INC.
485 ROUTE 1 SOUTH, BUILDING F, SUITE 320
ISELIN
NJ
08830
1
0
0
0
Stock Option (Right to Buy)
2.12
2021-10-05
4
A
0
34425
0.00
A
2031-10-05
Common Stock
34425
34425
D
The options were granted under the 2015 Plan in lieu of $60,000 cash fees payable under the Issuer's non-employee Director compensation program and vest in four equal quarterly installments on the last day of each fiscal quarter such that they are vested in full on September 30, 2022, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan.
/s/ Lawrence A. Kenyon, Attorney-in-Fact
2021-10-07